title: The effect of supportive E. coli mastitis treatment on PMN chemiluminescence and subpopulations of T lymphocytes.
abstract: The aim of this field study was to assess the impact of a single i.m. injection of lysozyme dimer and flunixin meglumine in combination with intramammary and systemic antibiotic on chemiluminescence of PMN (polymorphonuclear leucocytes) and subpopulations of lymphocyte T in blood of cows with E. coli mastitis. Examinations were performed on 30 dairy cows affected with naturally occurring acute form of E. coli mastitis. Cows were randomly divided into three groups according to the method of treatment. The first group was treated with approved intramammary antibiotic product, the same antibiotic in i.m. injection and one injection of flunixin meglumine on the first day of therapy. Next group was treated with the same antibiotic and additionally one injection of lysozyme dimer on the first day of therapy. The third one was treated only with an antibiotic and served as a control group. Blood samples were taken before treatment and on days 3 and 7. In samples haematology indices were determined, spontaneous and opsonised zymosan stimulated CL and PMA measurements were performed and the subpopulations of T lymphocyte (CD2(+), CD4(+), CD8(+)) were assayed in whole blood. There was no effect of the applied supportive treatment on the value of morphological blood indices. A significant influence of the time of sample collection on the level of CL and dynamics of lymphocytes T subpopulation was demonstrated. A single injection of flunixin meglumine or lysozyme dimer on the day of the beginning of treatment of E. coli mastitis, does not affect the level of neutrophil chemiluminescence and the percentage of T lymphocytes in the blood of mastitic cows in the analysed period of time.
authors.affiliation: Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, Al. Powstańców Wlkp. 10, 85-090 Bydgoszcz, Poland. hannamar@op.pl
authors.forename: H
authors.initials: H
authors.lastname: Markiewicz
authors.affiliation: Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, Al. Powstańców Wlkp. 10, 85-090 Bydgoszcz, Poland.
authors.forename: W
authors.initials: W
authors.lastname: Krumrych
authors.affiliation: Department of Animal Reproduction and Animal Health Protection, University of Technology and Life Sciences, 85-084 Bydgoszcz, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Gehrke
mesh_terms: D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002417:Cattle; D003002:Clonixin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000662:veterinary*; D005260:Female; D049449:Luminescence; D008414:Mastitis, Bovine / Q000188:drug therapy* / Q000382:microbiology; D009113:Muramidase; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D016176:T-Lymphocyte Subsets / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination; C014558:flunixin meglumine; D009113:Muramidase; D003002:Clonixin